Nova Scotia Becomes First Province to Publicly Reimburse JEMPERLI for the Treatment of Patients with Advanced or Recurrent dMMR/MSI-H Endometrial Cancer
Endometrial cancer is the most common gynaecological cancer, and its incidence has been steadily increasing over the past 20 years.[i] Approximately 20-29% of all endometrial cancers are dMMR/MSI-H and patients face… Read More




